List of Tables
Table 1. Global Janus Kinases Inhibitor Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Janus Kinases Inhibitor Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Janus Kinases Inhibitor Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Janus Kinases Inhibitor Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Janus Kinases Inhibitor Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Janus Kinases Inhibitor Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Janus Kinases Inhibitor Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Janus Kinases Inhibitor Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Janus Kinases Inhibitor Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Janus Kinases Inhibitor Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Janus Kinases Inhibitor Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Janus Kinases Inhibitor Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Janus Kinases Inhibitor Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Janus Kinases Inhibitor Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Janus Kinases Inhibitor Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Janus Kinases Inhibitor Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Janus Kinases Inhibitor Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Janus Kinases Inhibitor Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Janus Kinases Inhibitor Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Janus Kinases Inhibitor Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Janus Kinases Inhibitor Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Janus Kinases Inhibitor Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Janus Kinases Inhibitor Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Janus Kinases Inhibitor Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Janus Kinases Inhibitor Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Janus Kinases Inhibitor Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Janus Kinases Inhibitor Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Janus Kinases Inhibitor Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Janus Kinases Inhibitor Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Janus Kinases Inhibitor Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Janus Kinases Inhibitor Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Janus Kinases Inhibitor Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Janus Kinases Inhibitor Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Janus Kinases Inhibitor Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Janus Kinases Inhibitor Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Janus Kinases Inhibitor Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Janus Kinases Inhibitor Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Janus Kinases Inhibitor Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Janus Kinases Inhibitor Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Janus Kinases Inhibitor Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Janus Kinases Inhibitor Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Janus Kinases Inhibitor Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Janus Kinases Inhibitor Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Janus Kinases Inhibitor Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Janus Kinases Inhibitor Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Janus Kinases Inhibitor Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Janus Kinases Inhibitor Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Janus Kinases Inhibitor Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. AbbVie Company Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. AbbVie Janus Kinases Inhibitor Drugs Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Janus Kinases Inhibitor Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Galapagos Company Information
Table 81. Galapagos Description and Business Overview
Table 82. Galapagos Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Galapagos Janus Kinases Inhibitor Drugs Product
Table 84. Galapagos Recent Developments/Updates
Table 85. Gilead Sciences Company Information
Table 86. Gilead Sciences Description and Business Overview
Table 87. Gilead Sciences Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Gilead Sciences Janus Kinases Inhibitor Drugs Product
Table 89. Gilead Sciences Recent Developments/Updates
Table 90. Theravance Biopharma Company Information
Table 91. Theravance Biopharma Description and Business Overview
Table 92. Theravance Biopharma Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Theravance Biopharma Janus Kinases Inhibitor Drugs Product
Table 94. Theravance Biopharma Recent Developments/Updates
Table 95. Incyte Company Information
Table 96. Incyte Description and Business Overview
Table 97. Incyte Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Incyte Janus Kinases Inhibitor Drugs Product
Table 99. Incyte Recent Developments/Updates
Table 100. Eli Lilly and Company Company Information
Table 101. Eli Lilly and Company Description and Business Overview
Table 102. Eli Lilly and Company Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Eli Lilly and Company Janus Kinases Inhibitor Drugs Product
Table 104. Eli Lilly and Company Recent Developments/Updates
Table 105. CTI BioPharma Company Information
Table 106. CTI BioPharma Description and Business Overview
Table 107. CTI BioPharma Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CTI BioPharma Janus Kinases Inhibitor Drugs Product
Table 109. CTI BioPharma Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. GSK Janus Kinases Inhibitor Drugs Product
Table 114. GSK Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Novartis Janus Kinases Inhibitor Drugs Product
Table 119. Novartis Recent Developments/Updates
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sanofi Janus Kinases Inhibitor Drugs Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Bristol-Myers Squibb Company Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Bristol-Myers Squibb Janus Kinases Inhibitor Drugs Product
Table 129. Bristol-Myers Squibb Recent Developments/Updates
Table 130. Vertex Pharmaceuticals Company Information
Table 131. Vertex Pharmaceuticals Description and Business Overview
Table 132. Vertex Pharmaceuticals Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Vertex Pharmaceuticals Janus Kinases Inhibitor Drugs Product
Table 134. Vertex Pharmaceuticals Recent Developments/Updates
Table 135. Astellas Pharma Company Information
Table 136. Astellas Pharma Description and Business Overview
Table 137. Astellas Pharma Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Astellas Pharma Janus Kinases Inhibitor Drugs Product
Table 139. Astellas Pharma Recent Developments/Updates
Table 140. Amneal Pharmaceuticals Company Information
Table 141. Amneal Pharmaceuticals Description and Business Overview
Table 142. Amneal Pharmaceuticals Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Amneal Pharmaceuticals Janus Kinases Inhibitor Drugs Product
Table 144. Amneal Pharmaceuticals Recent Developments/Updates
Table 145. AstraZeneca Company Information
Table 146. AstraZeneca Description and Business Overview
Table 147. AstraZeneca Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. AstraZeneca Janus Kinases Inhibitor Drugs Product
Table 149. AstraZeneca Recent Developments/Updates
Table 150. Aclaris Therapeutics Company Information
Table 151. Aclaris Therapeutics Description and Business Overview
Table 152. Aclaris Therapeutics Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Aclaris Therapeutics Janus Kinases Inhibitor Drugs Product
Table 154. Aclaris Therapeutics Recent Developments/Updates
Table 155. BioCryst Pharmaceuticals Company Information
Table 156. BioCryst Pharmaceuticals Description and Business Overview
Table 157. BioCryst Pharmaceuticals Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. BioCryst Pharmaceuticals Janus Kinases Inhibitor Drugs Product
Table 159. BioCryst Pharmaceuticals Recent Developments/Updates
Table 160. Biogen Company Information
Table 161. Biogen Description and Business Overview
Table 162. Biogen Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Biogen Janus Kinases Inhibitor Drugs Product
Table 164. Biogen Recent Developments/Updates
Table 165. Reistone Biopharma Company Information
Table 166. Reistone Biopharma Description and Business Overview
Table 167. Reistone Biopharma Janus Kinases Inhibitor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Reistone Biopharma Janus Kinases Inhibitor Drugs Product
Table 169. Reistone Biopharma Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Janus Kinases Inhibitor Drugs Distributors List
Table 173. Janus Kinases Inhibitor Drugs Customers List
Table 174. Janus Kinases Inhibitor Drugs Market Trends
Table 175. Janus Kinases Inhibitor Drugs Market Drivers
Table 176. Janus Kinases Inhibitor Drugs Market Challenges
Table 177. Janus Kinases Inhibitor Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Janus Kinases Inhibitor Drugs
Figure 2. Global Janus Kinases Inhibitor Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Janus Kinases Inhibitor Drugs Market Share by Type: 2025 & 2032
Figure 4. Injectable Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Janus Kinases Inhibitor Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Janus Kinases Inhibitor Drugs Market Share by Application: 2025 & 2032
Figure 8. Oncology
Figure 9. Musculoskeletal
Figure 10. Gastroenterology
Figure 11. Other
Figure 12. Global Janus Kinases Inhibitor Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Janus Kinases Inhibitor Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Janus Kinases Inhibitor Drugs Sales (K Units), 2021–2032
Figure 15. Global Janus Kinases Inhibitor Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Janus Kinases Inhibitor Drugs Report Years Considered
Figure 17. Janus Kinases Inhibitor Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Janus Kinases Inhibitor Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Janus Kinases Inhibitor Drugs Players: Market Share by Revenue in Janus Kinases Inhibitor Drugs in 2025
Figure 20. Janus Kinases Inhibitor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Janus Kinases Inhibitor Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Janus Kinases Inhibitor Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Janus Kinases Inhibitor Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Janus Kinases Inhibitor Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Janus Kinases Inhibitor Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Janus Kinases Inhibitor Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Janus Kinases Inhibitor Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Janus Kinases Inhibitor Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Janus Kinases Inhibitor Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Janus Kinases Inhibitor Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Janus Kinases Inhibitor Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Janus Kinases Inhibitor Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Janus Kinases Inhibitor Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Janus Kinases Inhibitor Drugs by Type (2021–2032)
Figure 55. Global Janus Kinases Inhibitor Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Janus Kinases Inhibitor Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Janus Kinases Inhibitor Drugs by Application (2021–2032)
Figure 58. Global Janus Kinases Inhibitor Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Janus Kinases Inhibitor Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
